Show simple item record

dc.contributor.authorSmyth, E
dc.contributor.authorKouvelakis, K
dc.contributor.authorCunningham, D
dc.contributor.authorHahne, JC
dc.contributor.authorPeckitt, C
dc.contributor.authorVlachogiannis, G
dc.contributor.authorWatkins, D
dc.contributor.authorRao, S
dc.contributor.authorStarling, N
dc.contributor.authorWilson, SH
dc.contributor.authorWaddell, Thomas K
dc.contributor.authorOkines, A
dc.contributor.authorCrosby, T
dc.contributor.authorMansoor, Was
dc.contributor.authorWadsley, J
dc.contributor.authorMiddleton, G
dc.contributor.authorWotherspoon, A
dc.contributor.authorChau, I
dc.contributor.authorValeri, N
dc.date.accessioned2019-04-29T09:48:53Z
dc.date.available2019-04-29T09:48:53Z
dc.date.issued2018en
dc.identifier.citationSmyth E, Kouvelakis K, Cunningham D, Hahne JC, Peckitt C, Vlachogiannis G, et al. 646P EGFR amplification (amp) and survival in the REAL-3 trial. Annals of Oncology. 2018;29(suppl_8).en
dc.identifier.pmidNo PMIDen
dc.identifier.doi10.1093/annonc/mdy282.030en
dc.identifier.urihttp://hdl.handle.net/10541/621732
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdy282.030en
dc.titleEGFR amplification (amp) and survival in the REAL-3 trialen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentGastrointestinal Oncology, Royal Marsden Hospital NHS Foundation Trust, London, UKen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record